➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Diazoxide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for diazoxide and what is the scope of patent protection?

Diazoxide is the generic ingredient in three branded drugs marketed by Teva Branded Pharm, Abraxis Pharm, Schering, and E5 Pharma Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for diazoxide. Two suppliers are listed for this compound.

Recent Clinical Trials for diazoxide

Identify potential brand extensions & 505(b)(2) entrants

Albert Einstein College of Medicine, Inc.Phase 4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 4
National Institutes of Health (NIH)Phase 4

See all diazoxide clinical trials

Medical Subject Heading (MeSH) Categories for diazoxide

US Patents and Regulatory Information for diazoxide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
E5 Pharma Inc DIAZOXIDE diazoxide SUSPENSION;ORAL 211050-001 Dec 20, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Teva Branded Pharm PROGLYCEM diazoxide CAPSULE;ORAL 017425-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Schering HYPERSTAT diazoxide INJECTABLE;INJECTION 016996-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm DIAZOXIDE diazoxide INJECTABLE;INJECTION 071519-001 Aug 26, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.